法国系统性红斑狼疮住院患者中COVID-19相关器官衰竭后的生存情况:一项全国性研究
该研究基于法国全国医疗/行政医院数据库2011年1月至2020年11月的数据,分析系统性红斑狼疮(SLE)患者中COVID-19相关器官衰竭(AOF)的发生率、结局及相关因素。2020年3月至11月,法国127380次住院符合COVID-19-AOF定义,其中196次对应SLE患者;匹配后190例SLE合并COVID-19-AOF患者与908例非SLE COVID-19-AOF患者进行比较。第30天SLE组院内死亡43例(22.6%)vs 匹配非SLE组198例(21.8%),HR 0.98(0.71-1.34);第30至90天随访中,SLE组19例院内死亡(25.3%)vs 匹配对照组46例(15.4%),HR 1.83(1.05-3.20)。结论认为COVID-19-AOF与SLE患者较差的晚期预后相关。
要点
- 第30天SLE合并COVID-19-AOF患者院内死亡43例(22.6%)vs 匹配非SLE患者198例(21.8%),HR 0.98(0.71-1.34)。
- 第30至90天SLE组19例院内死亡(25.3%)vs 匹配对照组46例(15.4%),HR 1.83(1.05-3.20)。
- 结论认为COVID-19-AOF与SLE患者较差的晚期预后相关。
核心结论
- COVID-19-AOF与SLE患者较差的晚期预后相关。
研究设计与样本
- 采用法国全国医疗/行政医院数据库2011年1月至2020年11月数据的队列研究。
- 每例2020年11月前在法国医院诊断的SLE合并COVID-19-AOF患者按年龄±2岁、性别和合并症随机匹配5例非SLE合并COVID-19-AOF患者,采用精确匹配程序。
- COVID-19-AOF定义为至少一个COVID-19诊断编码与一个器官衰竭诊断编码的组合。
主要发现
- 2020年3月至11月,法国127380次住院符合COVID-19-AOF定义,其中196次对应SLE患者。
- 基于合并症匹配后,190例SLE合并COVID-19-AOF患者与908例非SLE合并COVID-19-AOF患者进行比较。
- 第30天,SLE合并COVID-19-AOF患者院内死亡43例(22.6%)vs 匹配非SLE合并COVID-19-AOF患者198例(21.8%),HR 0.98(0.71-1.34)。
- 第30至90天随访中,SLE组75例和匹配对照组299例被随访,SLE组院内死亡19例(25.3%)vs 匹配对照组46例(15.4%),SLE患者COVID-19-AOF后死亡HR为1.83(1.05-3.20)。
关键数值与推荐
- COVID-19-AOF定义为至少一个COVID-19诊断编码与一个器官衰竭诊断编码的组合。
- 第30天SLE组院内死亡43例(22.6%)vs 匹配非SLE组198例(21.8%),HR 0.98(0.71-1.34)。
- 第30至90天SLE组院内死亡19例(25.3%)vs 匹配对照组46例(15.4%),HR 1.83(1.05-3.20)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We analysed the incidence of, the specific outcomes and factors associated with COVID-19-associated organ failure (AOF) in patients with systemic lupus erythematosus (SLE) in France. METHODS: We performed a cohort study using the French national medical/administrative hospital database for the January 2011-November 2020 period. Each patient with SLE diagnosed in a French hospital with a COVID-19-AOF until November 2020 was randomly matched with five non-SLE patients with COVID-19-AOF. We performed an exact matching procedure taking age ±2 years, gender and comorbidities as matching variables. COVID-19-AOF was defined as the combination of at least one code of COVID-19 diagnosis with one code referring to an organ failure diagnosis. RESULTS: From March to November 2020, 127 380 hospital stays in France matched the definition of COVID-19-AOF, out of which 196 corresponded with patients diagnosed with SLE. Based on the presence of comorbidities, we matched 908 non-SLE patients with COVID-19-AOF with 190 SLE patients with COVID-19-AOF. On day 30, 43 in-hospital deaths (22.6%) occurred in SLE patients with COVID-19-AOF vs 198 (21.8%) in matched non-SLE patients with COVID-19-AOF: HR 0.98 (0.71-1.34). Seventy-five patients in the SLE COVID-19-AOF group and 299 in the matched control group were followed up from day 30 to day 90. During this period, 19 in-hospital deaths occurred in the SLE group (25.3%) vs 46 (15.4%) in the matched control group; the HR associated with death occurring after COVID-19-AOF among patients with SLE was 1.83 (1.05-3.20). CONCLUSIONS: COVID-19-AOF is associated with a poor late-onset prognosis among patients with SLE.
引用
- Mageau A, Papo T, Ruckly S, et al. Survival after COVID-19-associated organ failure among inpatients with systemic lupus erythematosus in France: a nationwide study. Ann Rheum Dis. 2021. PMID: 34893471. doi:10.1136/annrheumdis-2021-221599
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。